# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed Jun 17, 2026

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2026-06-17
- Accepted by EDGAR: Jun 17, 2026, 16:06 ET
- Period: 2026-06-16
- Accession: 0001104659-26-075130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000110465926075130/tm2617490d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000110465926075130/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000110465926075130/tm2617490d2_8k.htm

Filed Jun 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-075130. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.